Aminocaproic acid
This article needs additional citations for verification. (June 2016) |
Clinical data | |
---|---|
Trade names | Amicar |
AHFS/Drugs.com | Monograph |
MedlinePlus | a608023 |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Metabolism | Kidney |
Elimination half-life | 2 hours |
Identifiers | |
| |
JSmol) | |
Melting point | 205 °C (401 °F) |
| |
| |
(verify) |
Aminocaproic acid (also known as ε-aminocaproic acid, ε-Ahx, or 6-aminohexanoic acid) is a derivative and analogue of the
Nylon-6, where it is formed by ring-opening hydrolysis of caprolactam. The crystal structure determination showed that the 6-aminohexanoic acid is present as a salt, at least in the solid state.[4]
Medical use
Aminocaproic acid (Amicar) is FDA-approved for use in the treatment of acute bleeding due to elevated fibrinolytic activity.promyelocytic leukemia.[12]
References
- doi:10.5517/ccv38nv. Retrieved 18 August 2021.
- .
- ^ a b c "Amicar- aminocaproic acid solution Amicar- aminocaproic acid tablet". DailyMed. 9 October 2020. Retrieved 11 November 2020.
- doi:10.5517/ccv38nv, retrieved 24 October 2019
- ^ "Aminocaproic acid Orphan Drug Designations and Approvals". U.S. Food and Drug Administration (FDA). 6 January 1995. Retrieved 11 November 2020.
- PMID 9298049.
- PMID 2774776.
- PMID 6782532.
- PMID 26339364.
- PMID 7580358.
- S2CID 33961815.
- PMID 18613223.
Further reading
- Alkjaersig N, Fletcher AP, Sherry S (April 1959). "xi-Aminocaproic acid: an inhibitor of plasminogen activation". The Journal of Biological Chemistry. 234 (4): 832–837. PMID 13654273.
- Kang Y, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE (June 1987). "Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation". Anesthesiology. 66 (6): 766–773. PMID 3296855.